Epidemiology, treatment and outcomes of bloodstream infections due to MBL-producing Enterobacterales in France: A retrospective study
MBL-producing Enterobacterales BSIs are associated with high mortality. Early appropriate therapy and source control are critical. Resistance to last-line agents such as cefiderocol and aztreonam-avibactam calls for optimised empirical treatment guided by rapid diagnostics.
Authors
- Laurent Dortet (ORCID: https://orcid.org/0000-0001-6596-7384)
- B. Pilmis (ORCID: https://orcid.org/0000-0003-0238-1778)
Institutions
- Université Paris-Sud (FR)
- Inserm (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Université Paris-Saclay (FR)
- CEA Paris-Saclay (FR)
- Bicêtre Hospital (FR)
Publication Details
- Journal
- International Journal of Antimicrobial Agents
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1016/j.ijantimicag.2025.107630
- Citations
- 2
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 5.03